Itching is one of the most frequently reported side effects of COVID-19 vaccines, particularly the mRNA shots from Moderna and Pfizer-BioNTech. Data from large clinical trials put the rate of injection-site itching (pruritus) at roughly 35%, making it more common than swelling or redness, though less common than pain at the injection site. Itching that shows up away from the injection site is far less frequent but still well documented, and the ways it can present range from a mild local itch lasting a day to full-body hives that take nearly a week to clear.
How Common Is Injection-Site Itching
In the clinical trials that led to emergency authorization of the major COVID-19 vaccines, local injection-site reactions were tracked carefully. Pain was the standout complaint, reported by about 88% of recipients. Itching at the injection site came in at around 35%, redness at about 20%, and swelling at roughly 15%.1PubMed Central. Cutaneous findings following COVID‐19 vaccination: review of world literature and own experience That means more than one in three people who got the shot experienced some degree of itchiness right around where the needle went in, usually within the first few hours to a couple of days.
For most people, this kind of local itching is mild, peaks within a day or two, and resolves on its own without treatment. It belongs to the same family of minor injection-site complaints that accompany flu shots and other routine vaccinations, though the COVID vaccines seem to provoke them somewhat more often.
Itching and Rashes Away From the Injection Site
What surprised researchers early in the vaccine rollout was how many people developed skin symptoms that had nothing to do with the arm where they received the shot. A large survey study of tens of thousands of vaccine recipients found that rash and itching at locations other than the injection site was the single most common cutaneous reaction after both the first and second doses. After the first dose, about 1% of recipients reported it; after the second dose, the rate climbed slightly to about 1.6%.2JAMA Dermatology. Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines Those percentages sound small, but when hundreds of millions of doses are administered, even a 1-2% incidence rate translates to enormous numbers of people itching in places far from their shoulder.
A systematic review and meta-analysis of cutaneous adverse reactions across multiple vaccine types confirmed that, among non-local skin effects, different types of rashes, hives (urticaria), and angioedema were the most commonly reported.3PubMed Central. Cutaneous adverse reactions following COVID-19 vaccinations: A systematic review and meta-analysis Itching often accompanies these rashes, so the actual number of people who experienced some form of itch, whether local or generalized, is higher than any single category suggests.
What “COVID Arm” Is
One of the more distinctive itching reactions earned its own nickname early in the pandemic. “COVID arm” refers to a delayed hypersensitivity reaction that appears roughly a week after vaccination, typically with the Moderna mRNA vaccine. It shows up as a red, warm, itchy, and sometimes swollen patch at or near the injection site, often large enough to alarm people into thinking they have a skin infection.4PubMed Central. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis
A case series studying these delayed localized reactions in detail found they developed at a median of seven days after the Moderna shot, with the range spanning from two to twelve days. The affected patches were described as itchy, painful, and swollen pink plaques. When biopsied, the tissue showed a pattern consistent with a dermal hypersensitivity reaction, with immune cells including lymphocytes and eosinophils clustered around small blood vessels.5JAMA Dermatology. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series In plain terms, the immune system was reacting to something in the vaccine with a localized allergic-type response, not a bacterial infection.
This distinction matters practically because COVID arm was frequently misdiagnosed as cellulitis, a bacterial skin infection that requires antibiotics. In reality, COVID arm resolves on its own or with simple over-the-counter remedies, and antibiotics do nothing for it. If you develop a warm, itchy, red patch near your injection site about a week after your shot, cellulitis is far less likely than a delayed hypersensitivity reaction.
Hives After Vaccination
Beyond localized itching and COVID arm, some people broke out in hives (urticaria) after their COVID-19 vaccine. Hives involve raised, itchy welts that can appear anywhere on the body, and they represent a more systemic immune reaction than a patch of redness at the injection site. Urticaria has been described as a common cutaneous adverse event from COVID-19 vaccination.6PubMed Central. Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike protein
A study specifically examining delayed systemic urticaria found that symptoms typically appeared between 8 and 24 hours after vaccination, occurring with both the Pfizer-BioNTech and Moderna vaccines. Most patients needed antihistamines to manage the itch, and the median time to resolution was four days. Allergists performed excipient skin testing on nine of the twelve patients and all tests came back negative, meaning no specific vaccine ingredient could be pinpointed as the trigger through standard allergy testing.7PubMed Central. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination
That last point is worth sitting with. Most people who got hives after their COVID vaccine did not have a detectable allergy to any specific component of the vaccine. The reaction seems to be a broader immune system response rather than a classic ingredient-specific allergy, which is partly why predicting who will get hives is so difficult.
Why the Vaccine Can Trigger Itching
The major skin reactions to mRNA COVID-19 vaccines fall into two broad immunological categories. The first is what allergists call a type I hypersensitivity reaction, which includes hives and, at its most extreme, anaphylaxis. These are rapid-onset, driven by immune cells releasing histamine and other inflammatory molecules. The second is a type IV hypersensitivity reaction, which is slower to develop and includes COVID arm and certain rashes like erythema multiforme. Type IV reactions involve a different branch of the immune system and tend to appear days after the trigger rather than hours.
One case report dramatically illustrated the histamine side of things. A patient with an underlying mast cell disorder received the Moderna vaccine and experienced a surge in blood histamine levels that reached dangerous concentrations, accompanied by a spike in several inflammatory signaling molecules.8PubMed Central. COVID-19 mRNA-1273 vaccination induced mast cell activation with strongly elevated Th 2 cytokines in a systemic mastocytosis patient This is an extreme and rare scenario, but it illustrates the mechanism at work in milder form for many people: the vaccine activates certain immune cells, those cells release histamine, and histamine is the molecule that makes skin itch.
Polyethylene glycol (PEG), a stabilizer used in the mRNA vaccines, has also been investigated as a potential trigger for hypersensitivity reactions. PEG is found in many everyday products, from cosmetics to laxatives, and most people tolerate it without issue. But a small number of individuals are sensitized to it, and researchers have flagged it as one possible contributor to allergic-type reactions after COVID-19 vaccination.9PubMed Central. Hypersensitivity to polyethylene glycol in adults and children: An emerging challenge For the vast majority of people who experience itching, though, PEG sensitivity is unlikely to be the explanation. The itch is more often part of the general immune activation the vaccine is designed to produce.
Does the Itch Come Back With the Next Dose
One of the biggest practical questions for anyone who got itchy after their first COVID shot was whether it would happen again. A registry-based study of 414 patients who reported cutaneous reactions after their first mRNA vaccine dose found that 43% experienced a recurrence after the second dose.10Journal of the American Academy of Dermatology. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases That means a majority of people who had skin reactions the first time did not have them again, but a substantial minority did.
The study examining delayed urticaria specifically found that ten of twelve patients who had hives after an early dose chose to receive their next mRNA vaccine dose anyway. Of those ten, four experienced recurrent delayed hives.7PubMed Central. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination So the recurrence rate for hives was in a similar ballpark: not guaranteed, but not uncommon. The good news is that medical guidelines consistently said these reactions, while annoying, were not a reason to skip the next dose. The reactions were self-limiting and not considered dangerous.
When the Itch Might Not Be What You Think
Not every bout of itching after a COVID vaccine is a direct side effect. One factor that gets underappreciated is the nocebo effect, where people experience symptoms they expect to experience, regardless of the actual pharmacological cause. A case-control study of over 1,000 participants looked specifically at “allergy-like nocebo events” reported with COVID-19 vaccines. Among the 320 people classified as nocebo cases, skin symptoms were the most commonly reported complaint, showing up in about 72% of cases. The study also found that nocebo responses were more likely in people with a history of allergies and in people who rated the vaccine as less effective before receiving it.11Taylor & Francis Online / Expert Opinion on Drug Safety. Allergy-like nocebo events reported with COVID-19 vaccines: a case control study In other words, anxiety about the vaccine and a general tendency toward allergic reactions both made people more likely to report skin symptoms that could not be attributed to the vaccine itself through objective testing.
This does not mean you should dismiss your own itching as imaginary. It means that the picture is messier than “vaccine causes itch” in every case. Someone who is anxious about side effects and already prone to skin sensitivity may develop genuine itching that is partly driven by expectation rather than by the vaccine’s immunological activity. Distinguishing the two is clinically difficult, and for practical purposes most doctors treat the symptom the same way regardless of the underlying cause.
COVID-19 vaccines have also been associated with triggering less common skin conditions that cause itching. Pityriasis rosea, a skin condition that produces oval, scaly, itchy patches across the torso, has been reported as a rare post-vaccination event. Case reports have documented it appearing after COVID-19 vaccination, and it has been triggered by other vaccines in the past as well.12PubMed Central. Pityriasis Rosea Induced by COVID-19 Vaccination Pityriasis rosea is self-limiting and typically clears within a couple of months, but it can be intensely itchy and alarming if you do not know what it is. If you develop widespread scaly patches on your chest or back after a COVID vaccine, it is worth mentioning to a doctor rather than assuming it is a standard vaccine rash.
Managing Vaccine-Related Itching
For the overwhelming majority of people, itching after a COVID-19 vaccine needs nothing more than patience and basic over-the-counter care. A cool compress on the injection site helps with localized itch. Oral antihistamines like cetirizine or diphenhydramine are the standard go-to for more widespread itching or hives, and they were used successfully in most reported cases of delayed urticaria. Topical corticosteroid creams can help with localized patches like COVID arm.
The one scenario that requires immediate medical attention is if itching is accompanied by throat tightness, difficulty breathing, rapid heartbeat, dizziness, or widespread swelling, which could indicate anaphylaxis. Anaphylaxis after COVID vaccination is extremely rare, but it typically happens within minutes of the injection, which is why vaccination sites ask you to wait for a monitoring period afterward.
If you experienced a skin reaction to your first dose and are due for another, discussing it with your doctor is reasonable. But having had itching, a rash, or even hives is not typically considered a contraindication to receiving additional doses. As the recurrence data show, more than half of people who had a skin reaction the first time did not have one the second time.
The Limits of Adverse Event Reporting
It is worth understanding that much of what we know about post-vaccination skin reactions comes from a mix of clinical trials, case series, registry studies, and passive surveillance systems like the Vaccine Adverse Event Reporting System (VAERS) in the United States. VAERS data in particular should be interpreted carefully. The system relies on voluntary self-reporting, which means some people report reactions and others do not, and the reports alone cannot prove that the vaccine caused a given symptom.13PubMed Central. Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data This is a signal-detection tool, not a scorecard.
The clinical trial data and controlled studies cited throughout this article provide stronger evidence of causation. They show that itching is genuinely more common in vaccinated groups than in placebo groups, confirming it as a real side effect rather than just a coincidence. But the exact prevalence numbers will always carry some uncertainty because of differences in how studies defined and recorded skin symptoms. Some tracked “pruritus” specifically, others grouped it with rash, and still others relied on participants to self-report without standardized questionnaires. The overall picture, however, is consistent: itching is a common, well-documented, and overwhelmingly benign side effect of COVID-19 vaccination.
People With Pre-Existing Skin or Mast Cell Conditions
If you already have a condition that makes your skin reactive, such as chronic urticaria, eczema, or a mast cell disorder, the question of vaccine-related itching becomes more personal. The case of mast cell activation described earlier, where histamine levels shot up dramatically after the Moderna vaccine, is a reminder that people whose immune systems are already skewed toward releasing histamine may have amplified reactions.8PubMed Central. COVID-19 mRNA-1273 vaccination induced mast cell activation with strongly elevated Th 2 cytokines in a systemic mastocytosis patient That does not mean people with mast cell disorders should avoid vaccination. It means they and their doctors should plan for the possibility of a more pronounced reaction, potentially pre-medicating with antihistamines and arranging for a longer observation period after the shot.
For people with eczema or psoriasis, anecdotal reports during the rollout described flare-ups of their underlying condition after vaccination. This fits the general pattern: the vaccine stirs up the immune system, and in people whose skin is already a target of immune activity, that stirring can temporarily worsen things. These flares tend to settle within a few weeks and respond to the person’s usual management routine. If you have a chronic skin condition and are heading into a vaccine appointment, having your usual treatments on hand is a sensible precaution.